By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    physical health
    5 Ways Playing Games Can Improve Neural and Physical Health
    September 9, 2022
    Reasons For Hair Loss and Its Treatment
    Reasons For Hair Loss and Its Treatment
    February 16, 2022
    healthcare organization
    5 Actionable Strategies For Healthcare Organizations
    August 15, 2022
    Latest News
    Managing Your Health After a Worksite Accident
    December 8, 2023
    Biohazard Cleanup: The Importance of Proper Disposal and Containment
    December 2, 2023
    Medicare Helps Seniors, and People with Disabilities & ESRD
    November 27, 2023
    The Link Between Allergies and Sinusitis & Strategies for Relief
    November 27, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    When and How Much TasP is Value for Money?
    January 12, 2013
    supplements
    Regulate Supplements
    August 24, 2013
    cholera
    New IV Bag Designed for Relief Workers Can Sterilize Water
    November 17, 2013
    Latest News
    Automation in Pharmacovigilance: A Double-Edged Sword
    November 15, 2023
    What Does Science Say About Modern Health Practices?
    November 12, 2023
    Harnessing the Power of Email Marketing in Healthcare
    October 26, 2023
    10 Proven Strategies to Level Up Your Health Business
    October 25, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Most Common Male Sexual Dysfunction – Promising Results for Treatment
Share
Sign In
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Most Common Male Sexual Dysfunction – Promising Results for Treatment
Technology

Most Common Male Sexual Dysfunction – Promising Results for Treatment

HerinaAyot
Last updated: 2011/05/27 at 2:49 AM
HerinaAyot
Share
3 Min Read
SHARE

Premature ejaculation is a distressing male sexual dysfunction that is more common than erectile dysfunction (ED) and has a major impact on the quality of life for men and their sexual partners.

Premature ejaculation is a distressing male sexual dysfunction that is more common than erectile dysfunction (ED) and has a major impact on the quality of life for men and their sexual partners. Ampio Pharmaceuticals, Inc., a company focused on new uses for previously approved drugs and new molecular entities has completed analysis of the data from the Phase Three European clinical trials of Zertane, a repurposed drug used to treat premature ejaculation (PE). PE is the most common male sexual dysfunction, afflicting about 23% of all men between the ages of 18 and 75 years old.  Zertane was acquired in the company’s March, 2011 merger with DMI BioSciences, Inc.

“Completion of the Phase Three trials was particularly significant in that only about 15% of drugs that enter this phase have a successful outcome,” said Dr. David Bar-Or, founder and Chief Scientific Officer. “Further, the analysis of the trial results exceeded our expectations.  The data showed positive statistical significance in every category analyzed, with only very minor and minimal adverse events. This trial included 604 intent-to-treat patients, in a multi-center, double-blind, placebo-controlled design.”

“Ampio currently holds issued patents in 31 countries worldwide and has multiple additional patent applications which seek to protect related clinical indications for the drug,” continued Dr. Bar-Or.  ”This trial data is expected to allow Ampio to file a comprehensive application to selected European regulatory agencies to seek approval for commercialization of Zertane.”

The company, which recently commenced trading on the NASDAQ Capital Market under the ticker symbol “AMPE”,  is also performing a phase II clinical trial of Optina, a treatment for diabetic macular edema. Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction. By concentrating on development of new uses for previously approved drugs, approval timelines, costs and risk of clinical failure are reduced because these drugs have strong potential to be safe and effective while their shorter development times can significantly increase near term value. A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize Ampio’s product development programs.

 

TAGGED: medical technology, PE

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
HerinaAyot May 27, 2011 May 27, 2011
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article How to Start an Adult Discussion on Medicare
Next Article Device Separates Stem Cells During Surgery for PAD Treatment

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

Managing Your Health After a Worksite Accident
Managing Your Health After a Worksite Accident
Health December 8, 2023
How to Plan for a Dental Implant Procedure
How to Plan for a Dental Implant Procedure
Dental health December 8, 2023
weight loss
The Key Steps For Affective Weight Loss And Improving Health
Weight Loss Wellness December 6, 2023
Empowering Wellness: HBOT for Home Use Demystified
Empowering Wellness: HBOT for Home Use Demystified
Wellness December 5, 2023

You Might also Like

Medical Device Concept Development Paving the Way for Healthcare Innovations
Medical Devices

Medical Device Concept Development: Paving the Way for Healthcare Innovations

December 2, 2023
hearing aids
Wellness

Navigating the World of Hearing Aids with Confidence

November 29, 2023
healthcare business website
Technology

Choosing the Right Domain Name for Your Healthcare Business

November 27, 2023
healthcare software development
Technology

Shaping the Future of Healthcare Software Development

November 23, 2023
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US
© 2008-2023 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Lost your password?